lobbying_activities: 1811516

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1811516	1f54cde5-24e7-4433-9d6b-a727e5ce3e7a	Q1	EMPIRE CONSULTING GROUP	400703105	PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA	2016	first_quarter	PHA	Issues relating to Medicare Parts D and D; prescription drug costs/pricing;and 340 B drug pricing program.	HOUSE OF REPRESENTATIVES	40000		0	0	2016-04-18T15:38:56.430000-04:00